Remove tag payment-models
article thumbnail

Cartherics grants licence for CTH-004 to Shunxi

Pharmaceutical Technology

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. In animal models of ovarian cancer, it demonstrated promising results.

article thumbnail

Getting Started With Google Analytics 4 for Healthcare Brands

Healthcare Success

Here are just a few notable changes: Automatically collects website and app data across devices to provide a clearer picture of the customer journey Uses events-based tracking instead of session-based data Includes privacy controls like cookieless measurement Provides predictive capabilities to offer guidance without complex models.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What healthcare can learn from baseball’s predictive analytics

Clarify Health

Those who embrace this new model of provider performance benchmarking will have a clear advantage as the healthcare industry increasingly shifts from payments based on fee-for-service to those based on performance, also known as fee-for-value.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.